Pyridoxal kinases (PdxK) catalyze the phosphorylation of vitamin B6 precursors. Thus, these enzymes are an essential part of many metabolic processes in all organisms. The protozoan parasite Plasmodium falciparum (the main causative agent of Malaria tropica) possesses a unique de novo B6-biosynthesis pathway in addition to an interconversion pathway based on the activity of plasmodial PdxK (PfPdxK). The role of PdxK in B6 salvage has prompted previous authors to suggest PdxK as a promising target for structure-based antimalarial drug design. Here, the expression, purification, crystallization and preliminary X-ray diffraction analysis of PfPdxK are reported. PfPdxK crystals have been grown in space group P21, with unit-cell parameters a = 52.7, b = 62.0, c = 93.7 A°, α = 90 o , β = 95 o , γ = 90 o . A data set has been collected to 2 A° resolution and an initial molecular replacement solution is described.
Introduction
Malaria remains a major health problem, as approximately half of the world's population lives in regions where it is transmitted (i.e., in most parts of the tropics and subtropics). Malaria is caused by infection with one of several species of the genus Plasmodium, of which Plasmodium falciparum is responsible for the most severe and lethal form [1] . In 2012, Plasmodium infected over 200 million and killed at least 600,000 people worldwide [2] . The actual number of deaths and infections is likely to be higher, as in many cases the data is unavailable or undocumented. There is as yet no effective vaccine available against malaria and the parasite rapidly develops resistance to drugs used for its treatment, making the identification of new drug targets important for global health [3] [4] [5] . New antimalarial agents that provide higher efficacy and less toxicity are urgently required. A member of the ribokinase superfamily, pyridoxal kinase (PdxK) functions in the vitamin B 6 salvage pathway [6] and catalyzes the phosphorylation of pyridoxal, pyridoxine and pyridoxamine into precursors of the active form of B 6 (PLP) [7] . This active form is essential for both prokaryotes and eukaryotes as it is involved in a variety of metabolic processes as a cofactor, as well as in combating oxidative stress caused by singlet oxygen [8, 9] . For example PLP is an essential cofactor in the activity of plasmodial Aspartate aminotransferase (PfAspAT), which has been suggested to be a drug target as it bridges both carbon metabolism and nucleotide biosynthesis [10] [11] [12] . Unlike mammalian cells, P. falciparum has a functional pathway for B 6 de novo biosynthesis [13] , which has already been validated as a drug-target [14] . Additionally the parasite possesses an interconversion pathway based on PdxK, which has already been exploited for pro-drug discovery [15] . Pyridoxal kinases have been structurally characterized in several organisms including H. sapiens [16] , E. coli [17] , B. subtilis [18] , A. thaliana [19] and in the parasite T. brucei [20] . PdxK has been proven to be essential for growth of T. brucei, as knock-out parasites were unable to survive in PLP-free medium [21] . The availability of a crystal structure of the plasmodial PdxK (PfPdxK) is essential in the dissection of the unique vitamin B 6 salvage pathway of P. falciparum [13] and its validation as a drug target in the treatment of malaria. It will provide new details into the mechanism of the B 6 interconversion pathway and can also be used in comparative studies with PdxK homologs from other organisms. PfPdxK is a polypeptide of 497 amino acids with a predicted molecular mass of 57.2kDa [13] . Sequence analysis of wild-type PfPdxK shows that it contains a 205-amino-acid insert (109-314) that has no structural homologues. The 292 amino acids Nand C-terminal to this insert (51% of the sequence) can be aligned with the H. sapiens PdxK (GenBank accession O00764) with 32% identity, resulting in an overall identity of 16%. The structural and functional differences could be used in the design of selective antimalarials. Here we report the expression, purification, crystallization and preliminary X-ray diffraction characterization of PfPdxK.
Methods

Macromolecule production
Cloning of PfPdxK
The PdxK gene of P. falciparum was amplified by polymerase chain reaction (PCR) using P. falciparum 3D7 cDNA as template and sequence-specific sense (5'-GCGCCCGCGGTATGAAGAAGGAAAATATTATCTCC -3') and antisense (5'-GCGCCCATGGGCAAAAAAAACAGGCTCTTC-3') oligonucleotides containing AcII and NcoI restriction sites, respectively (Table 1). The PCR was performed with Pfu polymerase using the following conditions: one cycle of 367K for 7 min followed by 35 cycles of 1 min at 367K, 1.5 min at 315K and 2 min at 341K, according to [13] . The PCR fragments were cloned into pASK-IBA3 previously digested with BsaI and the nucleotide sequence was determined by automated sequencing (Seqlab, Germany). Nucleotide-sequence and protein-sequence analyses were performed using the software Gene Runner. The final construct consisted of full-length PfPdxK with the additional amino acids GHHHHHH (6 Histag) at the N-terminus (Table 1) .
Expression of PfPdxK
PfPdxK was recombinantly expressed in Escherichia coli Rosetta 2 (DE3) (Novagen) using the expression plasmid pASK-IBA3-PfPdxK, which contains the open reading frame for the PfPdxK gene fused to a N-terminal His-tag to facilitate purification. Recombinant protein was purified via nickel-chelating chromatography employing the N-terminal His tag according to the manufacturer's recommendations (Macherey and Nagel, Germany). Transformed E. coli Rosetta 2 (DE3) cells were propagated in 2L of selective media (LB in the presence of 50 μg mL -1 Ampicillin, 35 μg mL -1 Chloramphenicol, 4 mM MgCl 2 ) at 310K in 2L baffled Erlenmeyer flasks (Nalgene) and induced at an OD 600 of 0.6 with 200 ng mL -1 anhydrotetracycline (AHT). After induction, the temperature of the culture was lowered to 291K and the cells were incubated over night. Subsequently, they were harvested by centrifugation at 10,000 x g for 30 min.
Purification of PfPdxK
The bacteria pellet was resuspended in 30 mL Lysis buffer A [100 mM Tris pH 8.0, 300 mM NaCl, 20 mM imidazole, 5% (v/v) glycerol and 0.1 mM β-mercaptoethanol (BME)]. The cells were lysed on ice by sonication and the homogenate was clarified by centrifugation at 45'000 x g for 60 min. It was not necessary to supplement the lysis buffer with lysozyme as sonication was sufficiently effective. The supernatant containing the soluble His-tagged protein was filtered using a 0.45 μm filter (Whatman) and incubated for 10 min with 1.0 ml Ni-NTA affinity resin (Ni-NTA Agarose, Protino, Macherey Nagel, Germany) at room temperature. Recombinant protein was purified employing the C-terminal His-tag according to the manufacturer's recommendations. The following steps were also performed at room temperature as no significant protein degradation was observed. The resin was poured into a gravity-flow column (Bio-Rad) and washed with 50 mL lysis buffer (as defined above), followed by 10 mL wash buffer [100 mM Tris pH 8.0, 300 mM NaCl, 50 mM imidazole, 5% (v/v) glycerol, 3 mM BME]. The protein was eluted with elution buffer [50 mM Tris pH 8.0, 250 mM NaCl,
The eluate was collected and concentrated to a volume of 1 mL and applied onto a HiLoad 16/60 Superdex 75 column (GE Healthcare) previously equilibrated with 10 mM 2-(N-morpholino)ethanesulfonic acid (MES) pH 6.5, 100 mM NaCl, 100 mM ammonium nitrate, 5% v/v glycerol, 2mM BME. The gel-filtration buffer was chosen based upon a Thermofluor-based stability assay [22, 23] (Figure 1) , as previous crystallization attempts resulted in crystals unsuitable for diffraction experiments. Thermofluor data were collected on a CFX96 Real-Time System (Bio-Rad). SY-PRO Orange (Invitrogen) was added to the protein sample (concentrated to 2 mg mL -1 ) at 1:500 dilution. Experiments were composed of 45 μL of the buffer component to be screened and the 5 μL of the protein/dye solution. Inflection points in graphs of relative fluorescence units (RFU) against temperature were determined manually and used as an indicator of the sample thermal stability in the buffer component screened. Comparisons were made against a control sample containing only water. The final purified protein eluted as a single peak. This peak was pooled and concentrated using a Spin-X UF concentration unit with a 10 kDa cut-off (Corning). The final protein concentration was determined to be 10 mg mL -1 based upon its theoretical absorbance at 280 nm [Abs 0.1% (1 mg ml -1 ) = 0.49; http://web.expasy.org/protparam/]. The protein was immediately used in crystallization trials. The protein purity was estimated to be better than 95% (Figure 1a ) as assessed by Coomassie Brilliant Blue-stained SDS-PAGE [24] . The final yield of purified PfPdxK was approximately 5 mg per litre of culture.
Crystallization of PfPdxK
Concentrated protein was submitted to the EMBL Hamburg high-throughput crystallization facility [25] for initial screening against the Classics and Classics II Suites (Qiagen) sparse-matrix screening kits. All crystallization was performed at 293 K using equal volumes (200 nL) of protein solution and crystallization reagent. Small crystals were observed in multiple conditions. Manual hanging-drop optimization screens were performed around these conditions in order to reproduce and improve the crystal size by varying the precipitant concentration, buffer and pH. Optimised trials were performed using the hanging drop method, in which 1 μL of protein solution at a concentration of 10 mg mL -1 was mixed with an equal amount of reservoir solution and equilibrated over 1 mL of the reservoir solution at 293 K. Diffraction quality crystals were obtained in 0.1 M HEPES pH 7.75, 0.2 M CaCl 2 , 31% (v/v) PEG 400, 5% (v/v) glycerol (Table 2, Figure  2a ). Crystals appeared after 24 h and were suitable for diffraction studies after one week.
Data collection and processing
Diffraction analysis
PfPdxK crystals were directly flash-cooled to 100K in the nitrogen stream at the beamline. After initial analysis using the software BEST [26, 27] a 2.0-Å dataset was collected at X12 beamline (EMBL, DESY, Hamburg) using a beam size of 200 x 200 μm. Data-collection parameters are indicated in Table 3 . The space group of the PfPdxK crystals was determined to be P2 1 , with cell parameters of a=52.7, b=62.0, c=93,7, α=90 o , β=95 o , γ=90 o . Based on these cell parameters, a single PfPdxK molecule is expected in the asymmetric unit with a Matthews' coefficient of 2.87 Å 3 Da -1 and a solvent content of 57% [28] . Data were reduced using the XDS/SCALE [29, 30] . Data were merged using AIMLESS. An R free set [31] for use in subsequent structure refinement and validation was created using 5% of the reflections selected at random. The data set was examined for indications of twining, but no statistically significant twining could be found.
Molecular Replacement
Molecular replacement was performed using the BALBES pipeline [32] . Automated database searching within BALBES provided a number of homologous structures for use as molecular-replacement models. An initial solution was found using the coordinates of sheep brain PdxK (PDB entry 1RFU, [33] ) as a search model. This solution was found using the 1RFU structure sequence modified for molecular replacement to match the se Table 3 ). Crystallization parameters PfPdxK. When exposed to sodium chloride (i), BME (ii), ammonium chloride (iii) and MES pH 6.5
(iv) PfPdxK samples showed positive shift in thermal stability. PfPdxK crystal on beamline X12 at the EMBL, Hamburg. The edge of the detector corresponds to a resolution of 2 Å. The corresponding beamline parameters are given in Table 3 231
Results and Discussion
We have reported the availability of PfPdxK crystals suitable for diffraction analysis. The initial crystallization conditions for PfPdxK were obtained using the EMBL high-throughput crystallization facility [25] and subsequently refined using manual hanging drop screens. Small crystals (5-10 µm) were obtained when PfPdxK was concentrated in a buffer composed of 10 mM Tris pH 8.0, 150 mM NaCl prior to crystallization screening. However, the small crystal size resulted in poor diffraction (8-10 Å resolution) unsuitable for structure determination. An important step was the optimization of the gel-filtration buffer using the Thermofluor method [22, 23] . As shown in Fig. 1 (b) , PfPdxK shows increased thermal stability in the presence of β-mercaptoethanol (+5 K), ammonium chloride (+7 K) and MES pH 6.5 (+2 K) with respect to a water control. Thermofluor analysis also indicated that 100 mM NaCl was the optimal ionic strength of NaCl, with higher concentration of NaCl resulting in thermal destabilization. Optimized PfPdxK crystals suitable for diffraction measurements were obtained from the protein concentrated to 10 mg mL −1 in gel-filtration buffer in a 1:1 ratio with 0.1 M HEPES pH 7.75, 0.2 M CaCl 2 , 31% (v/v) PEG 400, 5% (v/v) glycerol. The optimized crystals used for data collection had maximal dimensions of 100 μm and diffracted to 2 Å resolution on beamline X12 at EMBL (Hamburg). The data collection and processing statistics are shown in table 3. While the data quality in the highest resolution bin is relatively poor (R merge = 51.7 %), sufficient signal exists for the use of this data in refinement based on maximum likelihood algorithms (I/s(I) = 2.03, [34] ). An example diffraction pattern is shown in Figure 2b . Initial molecular replacement trials were performed in BALBES [32] using REFMAC5 [34] and a potential solution was found using the coordinates of PdxK from sheep brain ( [33] , PDB entry 1RFU,), which showed 14% sequence identity overall (Figs. 3a,b ). There is a large insertion (104-309; 205 amino acids) in the PfPdxK sequence that has no structural homologue. While the remaining 303 amino acids of PfPdxK have a reasonable homology (28% identity) with 1rfu, we believe that this unmodelled portion may explain why the molecular-replacement solution and initial R factors are worse than might have been anticipated. However, the structure solution and refinement of PfPdxK are in progress and will be reported elsewhere. The determined structure is likely to aid in dissecting the plasmodial vitamin B 6 metabolism and further anti-malarial drug design. 
